Kunal Ahalpara

Kunal Ahalpara is an experienced professional in the biotechnology and pharmaceutical industries, currently serving as the Head of Quality Business Operations for Cell Therapy at Bristol Myers Squibb since January 2021. Prior to this role, Kunal held various leadership positions at Takeda from July 2013 to January 2021, including Head of Manufacturing Science & Technology and Associate Director roles in Manufacturing and Business Excellence. Kunal's earlier career includes significant positions at Amgen from August 2003 to July 2013, where roles spanned from Engineering Manager to Manufacturing Associate. Kunal holds a Master of Science in Chemical Engineering from the University of Massachusetts Lowell and a Bachelor of Engineering in Chemical Engineering from the University of Mumbai.